COMPANY PROFILE...A multi-licensed, vertically integrated provider of cannabis products and services with a focus on proprietary extraction processes. We bring pure, high quality cannabis

COMPANY PROFILE

CSE ticker: GW

A multi-licensed, vertically integrated provider of cannabis products and services with a focus on

proprietary extraction processes.

We bring pure, high quality cannabis products to medical, recreational, and international markets, while

growing the industry through testing and research.

VALENS GROWORKS

2

THE VALENS ADVANTAGESEED TO SALE

Different compounds are responsible for different desired results. By controlling our supply from the source right through to processing, we’re able to ensure our products’ qualities are maximized and purpose-driven.

PROPRIETARY

Our processing methods have been customized to ensure that the end product does not lose valuable compounds otherwise lost in the refining process.

PRODUCTS

The ability to produce a wide variety of products to the highest standards, allowing Valens to capitalize on multiple markets from medical to recreational to preferential method of consumption.

BRANDING

The Valens brand is quickly being recognized for delivering

the most science-backed, responsibly tested, sustainably

derived products in the market.

INDUSTRY-BACKED

A preferred partner of Canopy and others. The experience and reputation of the team at Valens speaks for itself.

USER BENEFITS

The Valens brand is quickly being recognized as the

science-backed, properly tested, properly derived products in the market.

LICENSED & CERTIFIED

Dealer’s License approved, ACMPR License pending, Hemp license pending, Nutraceutical license pending –setting Valens up for every servicing and consumer

product opportunity, globally.

3

Elevating Processes & Purity

Proprietary distilling process ensures versatile oils & extracts

Exceptionally pure product production

Free from additives & Adjuncts

Elevating Standards & Trust

ISO 17025 Accreditation – first ever in Canada for testing of cannabis

Exceed highest standards for Quality Assurance

Ensures consumers know products are safe

Ensures consumers know our brands can be trusted

Elevating Know-How

Proven leadership professionals

CEO with 17 years grassroots experience

Accredited and respected scientific product professionals

OUR ADVANTAGE: ELEVATING THE SECTOR

4

VALENSFARMS

SUPRA THCSERVICES INC.

VALENS AGRITECH LTD.

Creating a state of the art,

purpose built cultivation

facility up to 800,000 sq. ft

World-class, high capacity

cannabis extraction and

R&D facility

Full service testing

laboratory named the

“Center of Excellence for

Plant-Based Science” by

Thermo Fischer Scientific

OUR SUBSIDIARIES

5

Health Canada licensed cannabis extraction center

Cultivation & research center

Ability to import and export wholesale cannabis world-wide

Third party cannabis product development

Unique cannabis strain genetics

Proprietary, customized cannabis derivative production

78,000 kgs of Cannabis extraction per year and growing in our 25,000 sq/ft extraction plant

EU GMP Certification pending

OUR SUBSIDIARIES:VALENS AGRITECH LTD.

6

OUR SUBSIDIARIES:VALENS FARMS

A 400,000 (Phase 1) sqft purpose-built cannabis cultivation facility in the heart of B.C.’s Okanagan Valley:

City approval for up to 800,000 sqft of production space

Indoor and greenhouse growing territory

53,000 KG premium flower produced annually

Growing specific strains of cannabis through monocropping methodology strictly for extraction

Faster growing times means more crop turnover annually and less labour required

Valens practice of mono cropping means we deliver the highest quality cannabis plant possible. Grown in specific environments for specific strains

All Valens Farms product will be exclusively extracted by Valens Agritech and made into Valens branded product.

7

OUR SUBSIDIARIES:SUPRA THC SERVICES INC.

Health Canada licensed

Leading edge research facility

Specializing in testing of metals, pesticides, mold, terpene and CBD

ISO 17025 accreditation

“Center of Excellence in plant based science” named by $80B company (market cap) medical instruments company, Thermo Fischer Scientific

Setting the standard in Health-Canada required third party product verification for all LP’s

8

99

OUR REVENUE STEAMS:EXTRACTION

FLOWER High THC/CBD bud

V-Pucks, dose control

Pre-rolled joints

Accessories

(eg. rolling papers)

OIL/TINCTURES High THC/CBD

Vaporizer Cartridges

and Pens

Capsules

Concentrates

EDIBLES Healthy snack edibles – Trail mix, protein

bars, jerky

Appetizers

Food additives – Cooking oils, honey,

peanut butter

“Just add cannabis” – beverage

containers with cannabis oil preloaded

in the top, just like the vitamin waters

with the powder dispenser on top

Drinks – alcoholic (wine, beer),

non-alcoholic (juices, hot chocolate, coffee)

Oral sprays

TOPICALS Balms/creams/salves

Bath soaks/salts

Skin care products

Body Sprays

Lubricants

Essential Oils

Sublingual patches

Transdermal patches

Cannabis Oil – a flexible, value-add that can be used in an array of products using CBD, THC or both.

DIRECT SALES

EXPORT SALES

3RD PARTY RESEARCH & DEVELOPMENT

License allows development, testing and refining of

derivative products that fall outside ACMPR

OUR REVENUE STREAMS

10

PRODUCT DEVELOPMENT

Produce for some of the largest cannabis and

health companies

Ability to start production now of anticipated future

approved products

EXTRACTION

OILRevenue share

or fee for service

RESINFee for service

WHITE LABELPRODUCTS

Revenue Share

OUR INTERNATIONAL REACH:EXPORT OPPORTUNITIES WITH DEALERS LICENSE

CANADA -Rx 2001RECREATIONAL 2018

COLUMBIA -Rx 2017BRAZIL -Rx 2016PERU -Rx 2017

GERMANY-Rx 2017 MALTA -Rx 2018

AUSTRALIA -Rx 2017NEW ZEALAND -Rx 2017

JAMAICA -Rx 2017

IN NEGOTIATIONS WITH THE ABOVE MARKETS TO STRUCTURE PARTNERSHIPS AND DISTRIBUTION NETWORKS

GLOBAL MEDICAL MARIJUANA MARKET TO REACH $55.8 BILLION BY 2025

-Grandview Research

GLOBAL MEDICAL MARIJUANA MARKET WAS $11.5 BILLION IN 2015

-Grandview Research

AS OF JUNE 7, 2018, CANADA IS THE FIRST MEMBER OF THE G7 TO LEGAL-IZE CANNABISFOR RECREATIONAL USE ACROSS THE COUNTRY

GLOBAL MARKET

11

OUR PARTNERS

12

Kosha Projects Inc

MILESTONES ACHIEVED

Last $5M financing over-subscribed by $7.5M for a total of $12.5M; raised for the purposes of development and operations

1st extraction: Successful extraction of 100 kg of 100% cannabis oil used for research and development

1st harvest: Successful harvest of cannabis at Kelowna facility with THC content above industry standard

Increased extraction capacity by 600% with new monthly capacity of 6,500 KG

Kelowna facility in final stages of expansion to 25,000 Sq Ft with new office, extraction and processing space

Creation of Valens Farms in partnership with Kosha Projects to build 400,000 Sq Ft greenhouse in B.C.’s Okanagan Valley

Partnership agreement signed with SpeakEasy Growers to provide GMP-grade product, international development opportunities and more

13

FUTURE MILESTONES

2018

2019

1ST QUARTER

First planting in Valens Farms (Phase 1)

4TH QUARTER

First harvest of Phase 1B atValens Farms

2ND QUARTER

First harvest inValens Farms(Phase 1)

3RD QUARTER

First planting ofPhase 1B atValens Farms

1ST QUARTER

CompleteKelowna renovation

X

3RD QUARTER

Receipt of pending Hemp license

Nutraceutical site license

GMP certification complete

Launch of Valens-branded products line

Receipt of pending LP license to cultivate

4TH QUARTER

Begin sales of recreational cannabis products

Commence medical sales to international markets

2ND QUARTER

Begin offering white label and R&D to 3rd party

14

OUR TEAM

TYLER ROBSONCEO / DIRECTOR

Mr. Robson was Chief Operating Officer of the Company until taking the reins as Chief Executive Officer in May 2017, as well as remaining Director of Operations at Valens AgriTech Inc.

JOHN CULLENDIRECTOR

Mr. Cullen is a Co-Founder, Director and CEO of JHI Associates Inc. a private oil and gas exploration company with significant acreage in the deepwater offshore Guyana, South America.

ROBERT O’BRIENCSO / DIRECTOR / PRESIDENT OF SUPRA THC

Dr. O’Brien is an innovation solution provider with a strong experience base in analytical chemistry, laboratory and research team management, scientific education and corporate management.

CHRIS BUYSEN, MPAcc, CPA, CACFO

Mr. Buysen has over 15 years of diverse financial experience working as a senior financial executive with many public and private organizations in a wide range of industries including retail, pharmacy and consumer packaged goods.

SCOTT YOUNGINVESTOR RELATIONS & BUSINESS DEVELOPMENT

Mr. Young’s focus at Valens is corporate finance initiatives. Mr. Young has spent the past 15 years working in the capital market sectors of Canada, the United States and Europe.

QUINN SHISKINHEAD OF EXTRACTION AND PRODUCTION

Mr. Shiskin’s career emanates around production as a multi-ticketed Red Seal tradesman; where he worked in a variety of industries including mining, oil sands, LNG, pulp and paper, and in the construction industry.

JOHN W. CONROY, QC.ADVISOR

Mr. John Conroy has extensive background as legal counsel in constitutional, administrative and criminal law cases with respect to cannabis legislation, and acted as lead counsel in several ground-breaking legal proceedings.

CHANTEL POPOFFVICE PRESIDENT OF VALENS AGRITECH

In 2007, Ms. Popoff was appointed Director of Operations, then Director of Marketing for a fast-growing Western Canadian retail pharmacy chain. In 2013 she joined a natural health food company as Director of Marketing and was promoted to President in 2016.

15

PEER EVALUATION

JOHN W. CONROY, QC.ADVISOR

Mr. John Conroy has extensive background as legal counsel in constitutional, administrative and criminal law cases with respect to cannabis legislation, and acted as lead counsel in several ground-breaking legal proceedings.

16

MARKET CAP $95M $400M $273M $241M $141M

CURRENT PRODUCTION 6,000 Approx 14,500 217,000 4,000

CAPACITY 50,000

NEAR TERM

PRODUCTION 400,000 - 150,000 635,000 100,000 +

INCREASE 300,000

HIGH CAPACITY

EXTRACTION Y N N N N

IN HOUSE

EU GMP Y N N N N

CERTIFICATION

Valens GroWorks ("VGW") owns 100% of Valens Agritech and Supra THC

VGW currently has 2 dealers licenses with the ability to cultivate, research, test, store, sell, export and import. LP license approval imminent.

When VGW receives its LP it will be the one of only 8 Cannabis companies in Canada to have both Health Canada licenses.

Cultivation facility is built (GMP certification pending). Growing Cannabis is currently underway through VGW's Dealers License.

Construction of Valens Farms is underway, adding 400,000 sq ft cultivation capacity with the option to expand to 800,000 sq ft

VGW is currently in negotiations with a number of companies internationally to develop and produce Cannabis related products, edibles, sprays, nutrients, lights and vaporizers

Supra THC is the only Cannabis Laboratory in the world to receive the Thermo Fisher "Center of Excellence in Plant Based Medicines"

17

OUR SUMMARY

18

SCOTT YOUNGBUSINESS DEVELOPMENT/INVESTOR RELATIONS

[email protected](705) 888 - 2756VALENSGROWORKS.COM

130 ADELAIDE ST. W, OXFORD TOWER, SUITE 3002TORONTO, ON, M5H 3P5